BSE filing, NSE: HCG. Summary written from the filing by ALFA Finder's alert engine.
Healthcare Global Enterprises Ltd: key numbers
- Share price
- ₹589.70
- Market cap
- ₹8,804 Cr
- Revenue (annual)
- ₹2,545 Cr
- Net profit (annual)
- ₹13.76 Cr
- P/E (TTM)
- 386.2×Sector 51.1×
- Promoter holding
- 64.21%+0.00% QoQ
- FII holding
- 2.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Healthcare Global Enterprises Ltd
All →Healthcare Global Enterprises Board Meeting Date
HealthCare Global Enterprises will hold a board meeting on November 05, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Healthcare Global Enterprises Acquisition Worth ₹0 Cr
Healthcare Global's subsidiary, HCG Kenya, increased its stake in Advanced Molecular Imaging Limited (AMIL) to 50.10% by acquiring additional shares for approximately ₹0.003 Crore.
- Value
- ₹0.00 Cr
Healthcare Global Enterprises Other Announcement
The company clarified discrepancies in shareholding pattern filings, attributing differences to the timing of corporate actions following a rights issue and NDU disclosure variances.
Healthcare Global Enterprises Acquisition
Healthcare Global's subsidiary acquired an additional 0.10% stake in Advanced Molecular Imaging Limited for INR 0.00 Crore, making it a subsidiary of the company.
Healthcare Global Enterprises Other Announcement
Designated person Ashwini P Kavadimatti disclosed a pledge creation of 5,000 shares and a market sale of 500 shares of HealthCare Global Enterprises Ltd.
- Value
- ₹0.38 Cr
Healthcare Global Enterprises Annual General Meeting
HealthCare Global Enterprises held its 28th Annual General Meeting on September 18, 2026, via video conferencing to transact business items listed in the notice.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.